{
    "N/R/U": null,
    "Applicant": "VIVUS LLC",
    "BLA Number": "022523",
    "Proprietary Name": "Pancreaze",
    "Proper Name": "pancrelipase",
    "BLA Type": "351(a)",
    "Strength": "37,000USP UNITS; 97,300USP UNITS; 149,900USP UNITS",
    "Dosage Form": "Capsule, Delayed Release",
    "Route of Administration": "Oral",
    "Product Presentation": null,
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "April 26, 2021",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "16",
    "Submission Type": "Supplement",
    "License Number": "2197",
    "Product Number": "006",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "pancrelipase",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00085"
        }
    ]
}